Looming AstraZeneca pay row provides latest headache for chief executive Soriot

AstraZeneca (AZ), one of the drug-makers at the centre of the response to the COVID-19 pandemic, is bracing itself for a backlash over plans to increase the potential maximum pay package for its chief executive.